Clinical Trial Update: Duloxetine for the Treatment of Postpartum Depression [NA]

View source ↗

Summary

A Yale-sponsored clinical trial evaluating duloxetine for postpartum depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Yale University | Conditions: Postpartum Depression, Major Depressive Disorder | NA | Status: WITHDRAWN